These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27926924)

  • 1. The Impact of Excluding Trials from Network Meta-Analyses - An Empirical Study.
    Zhang J; Yuan Y; Chu H
    PLoS One; 2016; 11(12):e0165889. PubMed ID: 27926924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlapping network meta-analyses on the same topic: survey of published studies.
    Naudet F; Schuit E; Ioannidis JPA
    Int J Epidemiol; 2017 Dec; 46(6):1999-2008. PubMed ID: 29040566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015.
    Petropoulou M; Nikolakopoulou A; Veroniki AA; Rios P; Vafaei A; Zarin W; Giannatsi M; Sullivan S; Tricco AC; Chaimani A; Egger M; Salanti G
    J Clin Epidemiol; 2017 Feb; 82():20-28. PubMed ID: 27864068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported.
    James A; Yavchitz A; Ravaud P; Boutron I
    J Clin Epidemiol; 2018 May; 97():95-102. PubMed ID: 29196202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry.
    Cortese S; Tomlinson A; Cipriani A
    J Am Acad Child Adolesc Psychiatry; 2019 Feb; 58(2):167-179. PubMed ID: 30738544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid methods including network meta-analysis to produce evidence in clinical decision support: a decision analysis.
    Eiring Ø; Brurberg KG; Nytrøen K; Nylenna M
    Syst Rev; 2018 Oct; 7(1):168. PubMed ID: 30342549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of network meta-analyses for pharmacological treatment of common mental disorders.
    Williams T; Stein DJ; Ipser J
    Evid Based Ment Health; 2018 Feb; 21(1):7-11. PubMed ID: 29330217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Techniques Made Simple: Network Meta-Analysis.
    Watt J; Tricco AC; Straus S; Veroniki AA; Naglie G; Drucker AM
    J Invest Dermatol; 2019 Jan; 139(1):4-12.e1. PubMed ID: 30579427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review.
    Sullivan SM; Coyle D; Wells G
    PLoS One; 2014; 9(12):e113277. PubMed ID: 25517510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to Excluding Treatments in Network Meta-analysis.
    Lin L; Chu H; Hodges JS
    Epidemiology; 2016 Jul; 27(4):562-9. PubMed ID: 27007642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the characteristics of network meta-analyses on drug therapy: A systematic review.
    Tonin FS; Steimbach LM; Mendes AM; Borba HH; Pontarolo R; Fernandez-Llimos F
    PLoS One; 2018; 13(4):e0196644. PubMed ID: 29709028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior Choices of Between-Study Heterogeneity in Contemporary Bayesian Network Meta-analyses: an Empirical Study.
    Rosenberger KJ; Xing A; Murad MH; Chu H; Lin L
    J Gen Intern Med; 2021 Apr; 36(4):1049-1057. PubMed ID: 33403620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using decision thresholds for ranking treatments in network meta-analysis results in more informative rankings.
    Brignardello-Petersen R; Johnston BC; Jadad AR; Tomlinson G
    J Clin Epidemiol; 2018 Jun; 98():62-69. PubMed ID: 29454030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis of randomized clinical trials: reporting the proper summaries.
    Zhang J; Carlin BP; Neaton JD; Soon GG; Nie L; Kane R; Virnig BA; Chu H
    Clin Trials; 2014 Apr; 11(2):246-62. PubMed ID: 24096635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development.
    Carroll K; Hemmings R
    Pharm Stat; 2016; 15(2):135-42. PubMed ID: 26732132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis.
    Spineli LM
    BMC Med Res Methodol; 2019 Apr; 19(1):86. PubMed ID: 31018836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence inconsistency degrees of freedom in Bayesian network meta-analysis.
    Lin L
    J Biopharm Stat; 2021 May; 31(3):317-330. PubMed ID: 33296239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study.
    Gao Y; Shi S; Li M; Luo X; Liu M; Yang K; Zhang J; Song F; Tian J
    BMC Med; 2020 Jun; 18(1):120. PubMed ID: 32475340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics as effect modifiers for psoriasis biologic treatment response: an assessment using network meta-analysis subgroups.
    Wade R; Sharif-Hurst S; Dias S
    Syst Rev; 2020 Jun; 9(1):132. PubMed ID: 32503632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Meta-Analysis.
    Watt J; Del Giovane C
    Methods Mol Biol; 2022; 2345():187-201. PubMed ID: 34550592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.